Case and Quality Improvement Conference

January 7, 2016

9:00AM – 11:00AM

PCAM & Smilow

Dr. John Barbieri

University of Pennsylvania

Philadelphia, PA

Target Audience

This program has been designed for physicians, fellows, residents, medical students, QI professionals, quality care, risk management, professional nurses, advanced practice nurses and researchersin the medical specialties of dermatology.

Series Educational Objectives

After completing this activity, participants should be able to:

  • Diagnose a patient with a rare or difficult skin condition
  • Discuss the best treatments for rare dermatologic diseases using an interprofessional team approach
  • Recognize and treat dermatosis in the dermatologic patient
  • Reduce medical errors and unnecessary testing to improve quality of care and patient safety

Accreditation

Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Nurses: The Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Development is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Designation of Credit

Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 2 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Nurse participants will be awarded 2.0 contact hour.

Approved for (PSRM) patient safety/risk management designation

Acknowledgement of Commercial Support* NONE

For more information, please contact

Maria Torres

215-537-3387

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, MSN, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee & Presenter Name

William James, MD / Veronica Richardson, MSN, CRNP, ANP-BC / Misha Rosenbach, MD
Brandi Eldridge / Michelle Docimo / Maria Torres

Presenter Name

John Barbieri / Filberto Cedano-Laurent / Aileen Chang / Amy Forrestel / Sotonye Imadojemy
Carrie Kovarik, MD / Matthew LeBoeuf / Jules Lipoff, MD / David Margolis, MD, PhD / Sarah E. Millar
Christopher Miller, MD / Badri Modi, MD / Carolien Nelson / Lauren Orenstein / Lisa Pappas-Taffer
Douglas Pugliese, MD / Veronica Richardson / Todd Ridky, MD, PhD / Rudolf Roth, MD / Cory L. Simpson, MD, PhD
Waqas Shaikh / Joseph Sobanko, MD / John Stanley / Katherine Steele / Sasha Steven
Carmela Vittorio, MD / Joy Wan / Mackenzie Wehner

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.

Planning Committee & Presenter NameName of Commercial InterestRelationship

George Cotsarelis, MDAllergan, Johnson & JohnsonInvestigator

Presenter NameName of Commercial InterestRelationship

Aimee Payne, MD, PhDTG Therapeutics & SyntimmuneConsultant

John T. SeykoraMerck, NovartisConsultant

Rohto, Galderma, Samwumed, PiqueResearch Collaboration

Rosalie Elenitsas, MDMyriad GeneticsConsultant

Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

Disclosure of Unapproved Uses of Products

Presenter nameProductInvestigational and/or Off-label Use

Lisa Pappas-Tafferhydroxychloriqyube, Mycophenolate mofetil, Azathioprine, Quinidine, sodium Thiosulfate – Off Label